NFKB1 and neoplasm: The HCT15 lung metastasis C57BL/6 mouse model uncovered that AT-II treatment significantly suppresses N-cadherin, Wnt, p-NF-κB p65, and PD-L1 expression while increasing E-cadherin and Smad1 levels in tumor tissues [57].